But But But “A lateral flow tested by US firm Innova failed to detect three-in-10 cases with the highest viral loads in the key pilot scheme in Liverpool. The UK Government has spent £700m buying the Innova kits, which have until now ‘formed the lynchpin of its mass testing strategy’, reports the BMJ.”